Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduction of urinary albumin excretion and improvement of vascular stiffness with medium and high doses of olmesartan
2009-014349-10Phase 4Active
- Sponsor
- Institut d'Investigació Biomèdica de Girona
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of olmesartan in hypertension (HTN) and Microalbuminuria, sponsored by Institut d'Investigació Biomèdica de Girona. Primary endpoints: Reduction in urinary albumin excretion and Change in arterial stiffness. Started Jan 2010; status: active.
02
Drugs
olmesartan
03
Conditions
hypertension (HTN)Microalbuminuria
Beyond the preview
Go deeper on 2009-014349-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014349-10.